A carregar...
Eight Weeks of Ledipasvir/Sofosbuvir in Kidney Transplant Recipients With Hepatitis C Genotype 1 Infection
Short treatment duration of ledipasvir/sofosbuvir (LDV/SOF) has been successfully used to treat hepatitis C virus (HCV) genotype 1 infection in treatment-naive noncirrhotic patients with viral loads (VLs) under 6 million IU/mL. However, this short duration has not been studied in renal transplant re...
Na minha lista:
| Publicado no: | Transplant Direct |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Lippincott Williams & Wilkins
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5828686/ https://ncbi.nlm.nih.gov/pubmed/29536030 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/TXD.0000000000000744 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|